Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Irbesartan Water Content Determination Experiment: Methods, Standards, and Quality Control Applicati

Irbesartan water content determination is a critical quality control test that ensures the safety, stability, and efficacy of this widely used angiotensin II receptor antagonist in pharmaceutical manufacturing. This article provides a comprehensive technical overview of irbesartan moisture testing, covering sample types, Karl Fischer titration and loss-on-drying methodologies, pharmacopoeial standards, and practical applications in GMP laboratories. Whether you are developing an analytical method or outsourcing testing to an accredited third-party laboratory, this guide explains the experimental principles and regulatory expectations involved.

Technical Overview

Irbesartan is an orally active, non-peptide angiotensin II receptor antagonist (ARB) used for the treatment of hypertension and diabetic nephropathy in patients with type 2 diabetes mellitus. Chemically, it is a spirocyclic imidazolinone derivative, presented as a white to off-white crystalline powder that is practically insoluble in water and sparingly soluble in methanol and ethanol. Because irbesartan is a synthetic small molecule with limited hygroscopicity, its residual moisture is tightly controlled throughout manufacturing, packaging, and storage.

Water content determination is a core element of the quality control strategy for irbesartan. Excess moisture can promote hydrolytic degradation of the active pharmaceutical ingredient (API), affect powder flowability and compressibility during tableting, influence dissolution behavior, and support microbial proliferation in susceptible formulations. Major pharmacopoeias, including the Chinese Pharmacopoeia (ChP), the United States Pharmacopeia (USP), and the European Pharmacopoeia (EP), include water content limits within the irbesartan monograph, and the test is routinely performed in GMP-compliant laboratories and accredited third-party laboratories.

The most widely accepted technique for quantifying water in irbesartan is Karl Fischer (KF) titration, which offers high specificity, sensitivity at the microgram level, and rapid analysis. Complementary methods such as loss on drying (LOD) and thermogravimetric analysis (TGA) may be used for screening or comparative studies. This article outlines the experimental design, method parameters, and regulatory considerations for a typical irbesartan water content determination experiment.

Testing Samples

Irbesartan API (Drug Substance)

Bulk irbesartan powder sampled from final crystallization, drying, milling, or packaging stages. Representative sampling follows a statistically justified plan, and samples are protected from ambient humidity using sealed, moisture-barrier containers with desiccants. Typical acceptance criteria specified in pharmacopoeial monographs require water content not more than 0.5% (w/w), though the exact limit must always be verified against the current official monograph and the approved product specification.

Irbesartan Finished Dosage Forms

Film-coated tablets and immediate-release formulations containing irbesartan alone or in fixed-dose combination with hydrochlorothiazide. Tablet samples are ground gently and rapidly to minimize moisture exchange, then analyzed by KF titration using an appropriate solvent system or the KF oven technique.

Process Intermediates and Starting Materials

Wet cake from crystallization, dried granules, intermediates from synthesis routes, and excipients used in formulation (microcrystalline cellulose, lactose, croscarmellose sodium, and magnesium stearate) may be tested to establish drying endpoints and moisture budgets.

Stability and Packaging Samples

Samples drawn from ICH long-term, intermediate, and accelerated stability chambers, as well as materials stored in commercial packaging configurations, are tested periodically to monitor moisture uptake over the proposed shelf life.

Testing Items

The scope of an irbesartan water content determination experiment typically includes the following measurable parameters:

  • Water content by Karl Fischer titration, expressed as percentage (w/w) of the sample mass
  • Loss on drying (LOD) under defined temperature and time conditions
  • Moisture uptake and hygroscopicity classification under controlled humidity conditions
  • Water activity, where microbiological risk assessment is required
  • Drying curve characterization and residual solvent contribution, where applicable
  • Comparative evaluation of results against pharmacopoeial limits and internal specifications

Testing Methods

Volumetric Karl Fischer Titration

Volumetric KF titration is the preferred method for irbesartan API when expected water levels fall in the range of approximately 0.1% to 100%. The method is based on the stoichiometric reaction of water with iodine and sulfur dioxide in the presence of an alcohol and a base, typically imidazole in modern one-component reagents. A weighed sample of irbesartan (commonly 100 to 500 mg) is introduced into the titration cell containing methanol-based working medium, or a methanol-formamide mixture to improve solubility, and titrated to the electrometric endpoint detected by bivoltametric indication.

  • Reference standards: USP General Chapter <921> Water Determination, EP Method 2.5.12, and ChP general chapter 0832
  • Instrument calibration: standardization with certified water standards (e.g., 10 mg/g water in methanol) or disodium tartrate dihydrate
  • System suitability: verification of drift, blank, and recovery before sample analysis
  • Data output: water content calculated from titrant consumption, titer, and sample mass

Coulometric Karl Fischer Titration

For trace-level moisture (typically below 0.1%), coulometric KF offers superior sensitivity because iodine is generated electrochemically in situ. Because irbesartan is sparingly soluble, coulometric analysis is frequently combined with the KF oven method, in which the sample is heated in a sealed vial and evolved water is transferred to the cell by a dry carrier gas, eliminating matrix interference and solubility limitations.

Loss on Drying (Thermogravimetric Oven Method)

A complementary gravimetric method in which the sample is dried at a specified temperature, commonly 105°C, to constant mass under atmospheric or reduced pressure. LOD measures all volatile matter, including residual solvents, so it may overestimate water content relative to KF. It remains useful as a rapid in-process check when the drying profile is well characterized.

Thermogravimetric Analysis (TGA)

TGA provides a mass-loss profile as a function of temperature, allowing differentiation of surface moisture, bound water, and thermal degradation events. It is valuable during method development to select an appropriate KF oven temperature that liberates all moisture without decomposing the irbesartan matrix.

Method Validation and Quality Assurance

For GMP release testing, the KF method is validated in accordance with ICH Q2(R2) guidelines, covering the following attributes:

  • Specificity and absence of interference from irbesartan or excipients
  • Accuracy demonstrated by spike-recovery experiments at relevant water levels
  • Repeatability and intermediate precision across analysts and instruments
  • Linearity of the titration response and robustness to minor procedural variations
  • Control of environmental humidity, reagent standardization, and data integrity per ALCOA+ principles

Applications

Irbesartan water content determination supports multiple stages of the pharmaceutical product lifecycle:

  • API release testing: Confirming compliance of each drug substance batch with pharmacopoeial water limits before release for formulation
  • Process development: Defining drying endpoints in crystallization and fluid-bed operations, and establishing moisture budgets for unit operations
  • Formulation and tableting: Controlling moisture to ensure consistent compaction, disintegration, and dissolution of irbesartan tablets
  • Stability programs: Monitoring moisture migration under ICH Q1A(R2) storage conditions to justify shelf life and packaging selection
  • Supplier qualification: Evaluating contract manufacturers and raw material vendors against agreed moisture specifications
  • Regulatory submissions: Providing validated analytical data for marketing authorization dossiers, post-approval changes, and pharmacopoeial compliance statements
  • Combination products: Assessing moisture distribution in irbesartan-hydrochlorothiazide tablets, where hydrochlorothiazide hydrolysis risk adds criticality to moisture control

FAQ

Why is water content testing so important for irbesartan?

Although irbesartan itself is relatively stable and non-hygroscopic, residual moisture affects powder handling, tableting performance, dissolution, chemical stability of co-formulated actives such as hydrochlorothiazide, and compliance with pharmacopoeial monographs. Controlling water content is therefore a regulatory and quality requirement.

Which method is most appropriate: Karl Fischer titration or loss on drying?

Karl Fischer titration is the reference method because it selectively quantifies water, whereas loss on drying measures all volatile components. KF is preferred for release testing; LOD may be acceptable for in-process control when the volatile profile is fully characterized and justified.

What if irbesartan does not dissolve completely in the KF reagent?

Incomplete dissolution is acceptable as long as water is fully extracted, but for poorly soluble matrices the KF oven method is recommended. The sample is heated in a sealed vial at a temperature validated by TGA, and only the evolved water enters the titration cell, eliminating matrix effects.

How much sample is required for the experiment?

Volumetric KF typically requires 100 to 500 mg per determination, while coulometric KF with an oven requires only a few milligrams. Laboratories generally request one to two grams of sample to allow duplicates and repeat injections.

What are common sources of error in the experiment?

Frequent error sources include atmospheric moisture ingress during sample handling and grinding, reagent drift, incomplete water extraction, incorrect titer standardization, and carryover of residual solvents in LOD measurements. Proper dry-box handling, preconditioned vials, and system suitability checks mitigate these risks.

Which standards govern the test report?

Testing is performed against USP <921>, EP 2.5.12, ChP general chapters, and ICH Q2(R2) for validation. Reports issued by accredited third-party laboratories typically include methodology, instrument traceability, standardization records, individual and mean results, acceptance criteria, and a clear pass or fail conclusion.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing